Tuberous Sclerosis Complex Research Program
This grant funds innovative and translational research to improve understanding, prevention, and treatment of tuberous sclerosis complex, with a strong focus on clinical relevance and impact.
Funder: Military Health System Research Program
Due Dates (Anticipated): May 2026: Pre-application / Letter of Intent | August 2026: Full application deadline | August 2026: eBRAP pre-application submission
Funding Amounts: Clinical Translational Research Award: up to $1.6M (single PI) or $1.9M (partnering PI) over 3 years; Idea Development Award: up to $800,000 over 3 years; Exploration Award: up to $350,000 over 2 years.
Summary: Supports innovative, high-impact research to advance understanding, prevention, and treatment of tuberous sclerosis complex (TSC), emphasizing clinical and translational approaches.
Key Information: This is a forecasted opportunity; all deadlines are projected and subject to change.
Description
The Tuberous Sclerosis Complex Research Program (TSCRP) is a Congressionally Directed Medical Research Program (CDMRP) under the Department of Defense. Its mission is to support innovative and high-impact research that advances the understanding, prevention, and treatment of tuberous sclerosis complex (TSC), with a strong emphasis on projects that are clinically relevant and translational in nature. The program covers a range of topics, including neuropsychiatric disorders, tumor and cyst eradication, epilepsy, maternal-fetal and reproductive health, and the development of diagnostic and therapeutic technologies. Multiple award mechanisms are anticipated for FY26, each targeting different stages of research and investigator experience.
